Janaina Braga Medina

Janaina Braga Medina

Auto-generated profile, based on publicly available information

Janaina Braga Medina

Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, 15782, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain; Special Care Dentistry Centre (CAPE), School of Dentistry of University of São Paulo (FOUSP), São Paulo, Brazil; Department of Stomatology, School of Dentistry of University of São Paulo (FOUSP), São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2025 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
JMJanaina B. Medina
Janaina B. Medina
FSFábio França Vieira e Silva
Fábio França Vieira e Silva
RCRafael Antônio Velôso Caixeta
Rafael Antônio Velôso Caixeta
BRBruna de Oliveira Rech
Bruna de Oliveira Rech
APAlba Pérez-Jardón
Alba Pérez-Jardón
KOKarem Ortega
Karem Ortega
Background: Torque teno virus (TTV) is not known to cause disease in humans; however, chronic inflammatory conditions and immunosuppression states can favour TTV replication. This study aimed to verify the effectiveness of TTV as an immune biomarker.Methods: The protocol of this review was registered in PROSPERO (CRD42022331049) and performed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines.Results: Thirty‐three articles were selected and different groups of patients were assessed. In the solid organ and hematopoietic stem cell transplant groups, most studies reported that TTV viral load (VL) was highly detectable after transplantation and compared to controls, but the association with immune parameters showed conflicting results. In melanoma patients, no statistical difference in TTV VL was identified between susceptible and treatment‐resistant patients. In lung cancer patients, viral load increases significantly with disease progression but decreases after chemotherapy. HIV‐positive patients showed a higher VL than controls, but an inverse correlation with CD4+ was observed in half of the studies. Although 57.14% of all studies presented a low risk of bias, significant differences were observed between studies, particularly in the choice of the analyzed outcome, the parameter used to evaluate the patient's immune status, the presence of a control group, and the sample collection time points.Conclusions: Although TTV seems to have the potential to be a promising biomarker of immunosuppression, further high‐quality prospective clinical studies are still needed.

1 February 2022 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
JFJuliana Bertoldi Franco
Juliana Bertoldi Franco
NANatália Silva Andrade
Natália Silva Andrade
MBMarcus Vinicius Rodrigues da Silva Bueno
Marcus Vinicius Rodrigues da Silva Bueno
MPMaria Paula Siqueira de Melo Peres
Maria Paula Siqueira de Melo Peres
JMJanaina B. Medina
Janaina B. Medina
KOKarem Ortega
Karem Ortega

14 August 2023 in Oral Diseases
Verified
Journal Article
Open access
MFMarilia Andrade Figueiredo
Marilia Andrade Figueiredo
NANatalia Silva Andrade
Natalia Silva Andrade
ABAndrés Blanco-Carrión
Andrés Blanco-Carrión
JMJanaina Braga Medina
Janaina Braga Medina
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP
KOKarem Ortega
Karem Ortega
Objective: This work measures the intra‐operative bleeding in end‐stage renal disease patients and assesses whether laboratory coagulation tests and nitrogenous compounds are related to a higher bleeding risk.Methods: Laboratory tests were performed on the day of surgery and some patients with thrombocytopenia and values above the normal levels of international normalised ratio (INR), thrombin time (TT) and activated partial thromboplastin time (aPTT) were identified.Results: Haemostatic time ranged from 2 to 35 min (mean of 8.51 min) after suture. Bleeding volume ranged from 0.02 to 67.06 mL (mean of 4.38 mL) and the bleeding volume per minute ranged from 0.05 to 2.10 mL/min (median of 0.6 mL/min). Only seven patients (16.27%) had abnormal bleeding (more than 0.6 mL/min). Spearman's coefficient showed weak correlations between bleeding volume (mL/min) and serum urea (r = 0.226), TT (r = 0.227), plasma urea (r = 0.148) and creatinine (r = 146), as well as very weak correlations with all other variables (r < 0.140) such as age, haemodialysis time, glycaemia, glycated haemoglobin, platelets, INR, aPTT and fibrinogen.Conclusion: It was not possible to associate any laboratory test or nitrogenous compounds present in the blood and saliva with an increased bleeding.

11 December 2025 in Journal of Stomatology Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
JMJanaina B. Medina
Janaina B. Medina
WAWallena Albuquerque-Da-Cunha
Wallena Albuquerque-Da-Cunha
ABAndrés Blanco-Carrión
Andrés Blanco-Carrión
MPMaria Paula Siqueira de Melo Peres
Maria Paula Siqueira de Melo Peres
KOKarem Ortega
Karem Ortega
JFJuliana Bertoldi Franco
Juliana Bertoldi Franco

10 May 2024 in Special Care in Dentistry
Verified
Journal Article
Closed access
GMGabriella Bueno Marinho
Gabriella Bueno Marinho
JFJuliana Bertoldi Franco
Juliana Bertoldi Franco
JTJefferson R. Tenório
Jefferson R. Tenório
NANatália Silva Andrade
Natália Silva Andrade
RZRodrigo Melim Zerbinati
Rodrigo Melim Zerbinati
KOKarem Ortega
Karem Ortega

1 January 2025 in European Journal of Cancer Care
Verified
Journal Article
Open access
MMMariana Massuda
Mariana Massuda
GGGustavo Galvão
Gustavo Galvão
MBMarcelo Bonecker
Marcelo Bonecker
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP
JMJanaína B. Medina
Janaína B. Medina
JTJefferson R. Tenório
Jefferson R. Tenório
Malignant neoplasms of any anatomical site, along with their treatments, can significantly affect the oral health of paediatric and adolescent populations, potentially influencing their oral health–related quality of life (OHRQoL). This systematic review sought to evaluate how cancer, regardless of tumour location, impacts the OHRQoL of children and adolescents. Electronic searches were conducted in PubMed, Scopus, EMBASE, Web of Science and LILACS, as well as grey literature, up to October 2023. Clinical studies reporting on OHRQoL in patients aged 0–19 years with cancer were included. Two reviewers independently performed study selection, data extraction and risk of bias assessment using the Joanna Briggs Institute tools. Certainty of evidence was evaluated using the GRADE approach. Of 27,684 records, four studies (three cross‐sectional and one randomised clinical trial) met the inclusion criteria, encompassing 253 paediatric patients. OHRQoL was assessed using OHIP‐14 and ECOHIS instruments. Most studies reported a weak impact of oral health on quality of life. However, methodological limitations and very low certainty of evidence were identified. Although a weak impact of oral health on quality of life was observed among children and adolescents with malignant neoplasms, the limited number and quality of available studies prevent firm conclusions. High‐quality research with robust methodology is needed to better understand this relationship and draw robust conclusions and guide clinical decision‐making.